SPARC can act as both an inhibitor and promoter in cancer (Tai and Tang, 2008; Said, 2016; Li et al., 2019); the real effect of SPARC can be altered by other genes owing to its epistatic effects (Chen et al., 2018). Here, SPARC is linked to cancer.